questionsmedicales.fr
Comportement et mécanismes comportementaux
Comportement
Comportement impulsif
Comportement compulsif
Comportement toxicomaniaque
Comportement toxicomaniaque : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Addiction
Diagnostic médical
Tests psychologiques
Addiction
Professionnels de santé
Addiction
Signes cliniques
Addiction
Évaluation clinique
Addiction
Symptômes
5
Symptômes physiques
Addiction
Substances psychoactives
Addiction
Prévention
5
Soutien familial
Addiction
Activités de loisirs
Addiction
Campagnes de sensibilisation
Addiction
Traitements
5
Thérapie comportementale
Traitement de l'addiction
Thérapie cognitive
Addiction
Soutien de groupe
Addiction
Durée du traitement
Addiction
Complications
5
Maladies physiques
Addiction
Relations interpersonnelles
Addiction
Troubles psychologiques
Addiction
Facteurs de risque
5
Facteurs de risque
Addiction
Troubles mentaux
Addiction
Environnement social
Addiction
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Comportement toxicomaniaque : Questions médicales les plus fréquentes",
"headline": "Comportement toxicomaniaque : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Comportement toxicomaniaque : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Comportement toxicomaniaque"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Comportement compulsif",
"url": "https://questionsmedicales.fr/mesh/D003192",
"about": {
"@type": "MedicalCondition",
"name": "Comportement compulsif",
"code": {
"@type": "MedicalCode",
"code": "D003192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Addiction à la technologie",
"alternateName": "Technology Addiction",
"url": "https://questionsmedicales.fr/mesh/D000088942",
"about": {
"@type": "MedicalCondition",
"name": "Addiction à la technologie",
"code": {
"@type": "MedicalCode",
"code": "D000088942",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100.120.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dépendance à Internet",
"alternateName": "Internet Addiction Disorder",
"url": "https://questionsmedicales.fr/mesh/D000082424",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à Internet",
"code": {
"@type": "MedicalCode",
"code": "D000082424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100.120.875.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Comportement toxicomaniaque",
"alternateName": "Behavior, Addictive",
"code": {
"@type": "MedicalCode",
"code": "D016739",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Astrid Müller",
"url": "https://questionsmedicales.fr/author/Astrid%20M%C3%BCller",
"affiliation": {
"@type": "Organization",
"name": "Abteilung für Psychosomatische Medizin und Psychotherapie, Hannover Medical School, Hannover, Deutschland."
}
},
{
"@type": "Person",
"name": "Matthias Brand",
"url": "https://questionsmedicales.fr/author/Matthias%20Brand",
"affiliation": {
"@type": "Organization",
"name": "General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany; Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany. Electronic address: matthias.brand@uni-due.de."
}
},
{
"@type": "Person",
"name": "Elisa Wegmann",
"url": "https://questionsmedicales.fr/author/Elisa%20Wegmann",
"affiliation": {
"@type": "Organization",
"name": "General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany."
}
},
{
"@type": "Person",
"name": "Mark D Griffiths",
"url": "https://questionsmedicales.fr/author/Mark%20D%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK."
}
},
{
"@type": "Person",
"name": "Yui Asaoka",
"url": "https://questionsmedicales.fr/author/Yui%20Asaoka",
"affiliation": {
"@type": "Organization",
"name": "Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personality assessment with Temperament and Character Inventory in Parkinson's disease.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36030666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an Inconsistent Responding Scale for the HEXACO Personality Inventory-Revised.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36859786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911231157620"
}
},
{
"@type": "ScholarlyArticle",
"name": "Construction of item-level scales from the Personality Assessment Inventory to assess levels of personality functioning.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227863",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000628"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of personality disorder in the ICD-11 diagnostic system: Polish validation of the Personality Inventory for ICD-11.",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/37098193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/138563"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item response theory analysis of the University Personality Inventory in medical students.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37366154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/npr2.12362"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Comportement",
"item": "https://questionsmedicales.fr/mesh/D001519"
},
{
"@type": "ListItem",
"position": 4,
"name": "Comportement impulsif",
"item": "https://questionsmedicales.fr/mesh/D007175"
},
{
"@type": "ListItem",
"position": 5,
"name": "Comportement compulsif",
"item": "https://questionsmedicales.fr/mesh/D003192"
},
{
"@type": "ListItem",
"position": 6,
"name": "Comportement toxicomaniaque",
"item": "https://questionsmedicales.fr/mesh/D016739"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Comportement toxicomaniaque - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Comportement toxicomaniaque",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Comportement toxicomaniaque",
"description": "Comment diagnostiquer une addiction ?\nQuels tests sont utilisés pour l'addiction ?\nQui peut diagnostiquer une addiction ?\nQuels signes indiquent une addiction ?\nQuelle est la durée pour un diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Comportement toxicomaniaque",
"description": "Quels sont les symptômes d'une addiction ?\nComment l'addiction affecte-t-elle le comportement ?\nY a-t-il des symptômes physiques d'addiction ?\nLes symptômes varient-ils selon la substance ?\nComment reconnaître une rechute ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Comportement toxicomaniaque",
"description": "Comment prévenir l'addiction ?\nLes programmes scolaires aident-ils à prévenir l'addiction ?\nLe soutien familial joue-t-il un rôle ?\nLes activités de loisirs aident-elles à prévenir l'addiction ?\nLes campagnes de sensibilisation sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Comportement toxicomaniaque",
"description": "Quels traitements sont disponibles pour l'addiction ?\nLa thérapie cognitive est-elle efficace ?\nQuels médicaments sont utilisés pour traiter l'addiction ?\nLe soutien de groupe est-il bénéfique ?\nCombien de temps dure un traitement d'addiction ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Comportement toxicomaniaque",
"description": "Quelles complications peuvent survenir avec l'addiction ?\nL'addiction peut-elle entraîner des maladies physiques ?\nComment l'addiction affecte-t-elle les relations ?\nY a-t-il des risques de suicide liés à l'addiction ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Comportement toxicomaniaque",
"description": "Quels sont les facteurs de risque d'addiction ?\nL'âge influence-t-il le risque d'addiction ?\nLe stress est-il un facteur de risque ?\nLes troubles mentaux augmentent-ils le risque d'addiction ?\nL'environnement social joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Personality+Inventory#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une addiction ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, des antécédents et des évaluations psychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'addiction ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires standardisés et des évaluations cliniques sont utilisés pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Qui peut diagnostiquer une addiction ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé, comme un psychiatre ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une addiction ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent la perte de contrôle, le besoin compulsif et des conséquences négatives."
}
},
{
"@type": "Question",
"name": "Quelle est la durée pour un diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic peut prendre plusieurs séances pour évaluer les comportements et les impacts."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une addiction ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'irritabilité, l'anxiété, et des changements d'humeur fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'addiction affecte-t-elle le comportement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des comportements impulsifs, des conflits interpersonnels et des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques d'addiction ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des tremblements, des nausées et des douleurs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la substance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la substance utilisée, comme l'alcool ou les opioïdes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une rechute ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une rechute se manifeste par le retour à l'usage compulsif après une période d'abstinence."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'addiction ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et le soutien social dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires aident-ils à prévenir l'addiction ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes éducatifs sur les risques des substances peuvent réduire l'usage précoce."
}
},
{
"@type": "Question",
"name": "Le soutien familial joue-t-il un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un soutien familial solide peut diminuer le risque d'addiction chez les jeunes."
}
},
{
"@type": "Question",
"name": "Les activités de loisirs aident-elles à prévenir l'addiction ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités de loisirs saines peuvent offrir des alternatives à l'usage de substances."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent la conscience des dangers et peuvent réduire l'usage de substances."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'addiction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, les médicaments et le soutien de groupe."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cognitive aide à modifier les pensées et comportements liés à l'addiction."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter l'addiction ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agonistes opioïdes et les antidépresseurs peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Le soutien de groupe est-il bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien de groupe offre un environnement de partage et de motivation pour la sobriété."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement d'addiction ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années selon les besoins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'addiction ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de santé mentale, des maladies physiques et des conflits sociaux."
}
},
{
"@type": "Question",
"name": "L'addiction peut-elle entraîner des maladies physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'addiction peut causer des maladies comme des troubles hépatiques, cardiaques ou pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment l'addiction affecte-t-elle les relations ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des conflits, des ruptures et un isolement social significatif."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de suicide liés à l'addiction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes dépendantes présentent un risque accru de comportements suicidaires."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'addiction est souvent associée à des troubles comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'addiction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et l'environnement social."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'addiction ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes sont plus vulnérables en raison de la recherche de sensations et de l'immaturité."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter le risque d'usage de substances comme mécanisme d'adaptation."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux augmentent-ils le risque d'addiction ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des troubles mentaux sont plus susceptibles de développer une addiction."
}
},
{
"@type": "Question",
"name": "L'environnement social joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement social favorable à l'usage de substances augmente le risque d'addiction."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Abteilung für Psychosomatische Medizin und Psychotherapie, Hannover Medical School, Hannover, Deutschland.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany; Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany. Electronic address: matthias.brand@uni-due.de.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, University of Southern California, 2001 N Soto St., Los Angeles, CA 90032, USA.
Department of Psychology, University of Southern California, 3620 South McClintock Ave, Los Angeles, CA 90089, USA.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Mainz, Mainz, Deutschland.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Departments of Psychiatry, Neuroscience and Child Study, Yale University School of Medicine, New Haven, USA; Connecticut Council on Problem Gambling, Wethersfield, USA; Connecticut Mental Health Center, New Haven, USA.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Bar-Ilan University, Ramat-Gan 52900, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel; Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Faculty of Education, Society and Culture, Beit-Berl College, Kfar-Saba 4490500, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Bar-Ilan University, Ramat-Gan 52900, Israel; Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel; Department of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza (C8-746), University of California, Los Angeles (UCLA), California 90095, United States. Electronic address: yurir@biu.ac.il.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Psychology Research Laboratory, Ospedale San Giuseppe, IRCCS Istituto Auxologico Italiano, 28824 Verbania, Italy.
Department of Psychology, Catholic University of Milan, 20123 Milan, Italy.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Psychobiology and Methodology, Autonomous University of Barcelona, 08193 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
There is a growing interest in personality evaluation in Parkinson's disease (PD), following observations of specific temperaments in PD patients. Therefore, our objective was to evaluate personality ...
Fluctuating PD patients from the PREDISTIM cohort were included. Description of TCI dimensions and comparison with a French normative cohort were performed. Pearson correlations between TCI dimensions...
The 570 PD patients presented significant higher scores in Harm Avoidance, Reward Dependence, Persistence, Self-Directedness and Cooperativeness and significant lower scores in Self-Transcendence comp...
The TCI seems to be an adequate tool to evaluate personality dimensions in PD with good structural and internal consistencies. These fluctuating PD patients also have specific personality dimensions c...
Inconsistent or careless responding is a significant threat to the validity of self-reported personality data. Using archival samples of undergraduate and community participants, we developed an incon...
The fifth edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-5; American Psychiatric Association, 2013) introduced the clinician-rated Levels of Personality Functioning Scale (...
This paper presents results of a study on the Polish adaptation of the Personality Inventory for ICD-11 (PiCD), which was developed to measure pathological traits under a new, dimensional model of per...
The study involved a non-clinical sample of N = 597 adults (51.4% female; Mage = 30.24 years; SD = 12.07 years). For convergent and divergent validity, Personality Inventory for DSM-5 (PID-5) and Big ...
The results showed the Polish adaptation of the PiCD to be reliable and valid. Cronbach's alpha coefficient for PiCD scale scores ranged from 0.77 to 0.87 (Mα = 0.82). The four-factor structure of PiC...
Obtained data demonstrate satisfactory internal consistency, factorial validity, and convergent-discriminant validity of the Polish adaptation of PiCD in a non-clinical sample....
Young adulthood has been recognized as an important period for the transition from adolescence to adulthood. The University Personality Inventory (UPI), a mental health questionnaire for young adultho...
Japanese medical students (n = 1185) participated in this study, and the UPI was completed at the time of university admission. The two-parameter IRT model was used to assess the measurement character...
Among all participants, 35.4% (420/1185) had total UPI score of 21 or more, and 10.6% (126/1185) indicated that they had the idea of wanting to die (item 25). For further IRT analysis, unidimensionali...
The UPI is useful to assess mild or moderate mental health problems, while precision may decline among individuals experiencing both little and extremely high levels of stress. Our findings provide a ...
The International Classification of Diseases 11th Revision (ICD-11) personality disorder model comprises, among other elements, five maladaptive personality trait domains (negative affectivity, detach...
The current study contributed to the validation of the PiCD validation by exploring its stability and predictive links with psychological distress over 6 months in a sample of 206 German community adu...
The PiCD trait domain scales displayed strong differential (all r ≥ .80) and absolute stability (all |d| ≤ .09). Additionally, PiCD negative affectivity predicted depression, anxiety, and stress, and ...
In sum, this study demonstrated the stability of the PiCD trait domain scores, supporting their utility for capturing relatively stable traits as described in the ICD-11. Additionally, we provided the...
In order to assess the internal consistency, fit indexes, test-retest reliability, and validity of the Personality Inventory for the DSM-5 (PID-5) and its associations with age, gender, and education,...
We found that; (a) temporal consistency of the Hungarian PID-5 was confirmed by one-month test-retest reliability analysis, (b) validity of the PID-5 instrument is acceptable in the clinical and the n...
These findings support that the Hungarian PID-5 is a reliable and valid instrument for both clinical and non-clinical populations....
The Personality Inventory for...
The relationship between maladaptive personality traits and psychotic disorders in the early stages of disease has not been thoroughly investigated, even though it is essential for developing preventi...
The five domains and the 25 facets of the Personality Inventory for DSM-5 (PID-5) were compared between 102 patients with recent-onset psychosis (ROP) and 116 community subjects (C) with a general lin...
Patients with ROP, compared to C, exhibited higher scores in four out of the five domains with medium effect sizes (Cohen's f...
Maladaptive personality traits were prominent in persons with ROP. These findings suggest that personality traits might play a role in vulnerability to psychosis and highlight the importance of evalua...
The current manuscript presents the convergence of the Dimensional Assessment of Personality Pathology (DAPP-BQ), using its short form the DAPP-90, and the Five-Factor Personality Inventory for Intern...